IL-10 plays a prominent role in counterbalancing Th1 and Th17 immune activity in IBD towards a Th2 response by downregulating antigen presentation and subsequent release of pro-inflammatory cytokines thereby attenuating mucosal inflammation [60]. This evidence concerns the gene IL10 and inflammatory bowel disease.